bromocriptine has been researched along with nadp in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Delaforge, M; Mansuy, D; Peyronneau, MA; Renaud, JP; Riviere, R | 1 |
Boucher, JL; Delaforge, M; Mansuy, D; Ouazzani, J; Renodon, A; Sari, MA | 1 |
Denisov, IG; Grinkova, YV; McLean, MA; Sligar, SG | 1 |
3 other study(ies) available for bromocriptine and nadp
Article | Year |
---|---|
High affinity of ergopeptides for cytochromes P450 3A. Importance of their peptide moiety for P450 recognition and hydroxylation of bromocriptine.
Topics: Animals; Bromocriptine; Cytochrome P-450 CYP2E1; Cytochrome P-450 Enzyme System; Dexamethasone; Dihydroergotamine; Ergolines; Humans; Hydroxylation; Isoenzymes; Lysergic Acid; Microsomes, Liver; Mixed Function Oxygenases; NADP; Oxidation-Reduction; Peptides; Rats; Recombinant Proteins; Saccharomyces cerevisiae; Substrate Specificity | 1994 |
Bromocriptine is a strong inhibitor of brain nitric oxide synthase: possible consequences for the origin of its therapeutic effects.
Topics: Animals; Brain; Bromocriptine; Catalysis; Enzyme Inhibitors; Mice; Mice, Inbred C3H; NADP; Nitric Oxide Synthase; Oxidation-Reduction; Rats; Recombinant Proteins | 1997 |
Oxidase uncoupling in heme monooxygenases: human cytochrome P450 CYP3A4 in Nanodiscs.
Topics: Bromocriptine; Catalysis; Cytochrome P-450 Enzyme System; Heme Oxygenase (Decyclizing); Humans; NADP; Nanoparticles; Oxidation-Reduction; Testosterone | 2013 |